ReviewCurrent hematologic malignancy reports2024
JAK Inhibitors for Myelofibrosis: Strengths and Limitations.
K Thaw et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ReviewCurrent hematologic malignancy reports2024
K Thaw et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.